We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dr. Reddy's Drops Patent Challenge To Glaxo's Zofran

Law360 (April 29, 2004, 12:00 AM EDT) -- Indian generic drug maker Dr. Reddy's Laboratories has withdrawn its challenge to the main U.S. patent on GlaxoSmithKline anti-nausea drug Zofran, the U.K. drug maker said on Thursday.

As a result,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.